Matrix Asset Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,032
Closed -$2.7M 113
2025
Q4
$2.7M Sell
30,032
-90,174
-75% -$8.55M 0.24% 52
2025
Q3
$11.8M Sell
120,206
-6,717
-5% -$666K 1.1% 35
2025
Q2
$11.6M Sell
126,923
-4,173
-3% -$404K 1.17% 34
2025
Q1
$14.8M Buy
131,096
+40,869
+45% +$4.37M 1.64% 27
2024
Q4
$9.53M Sell
90,227
-9,268
-9% -$994K 1.04% 36
2024
Q3
$10.7M Sell
99,495
-616
-0.6% -$67.2K 1.19% 33
2024
Q2
$10.9M Sell
100,111
-70
-0.1% -$8.25K 1.3% 33
2024
Q1
$13.2M Sell
100,181
-1,991
-2% -$249K 1.58% 29
2023
Q4
$12.4M Buy
102,172
+21,459
+27% +$2.39M 1.58% 27
2023
Q3
$9.06M Buy
80,713
+19,928
+33% +$2.53M 1.29% 34
2023
Q2
$8.85M Sell
60,785
-22,197
-27% -$3.02M 1.22% 36
2023
Q1
$10.7M Sell
82,982
-10,694
-11% -$1.34M 1.55% 28
2022
Q4
$11.9M Sell
93,676
-9,776
-9% -$1.13M 1.79% 20
2022
Q3
$10.8M Sell
103,452
-263
-0.3% -$28.9K 1.77% 25
2022
Q2
$10.9M Buy
103,715
+13,056
+14% +$1.55M 1.67% 28
2022
Q1
$11.6M Buy
90,659
+10,842
+14% +$1.31M 1.56% 33
2021
Q4
$9.85M Buy
79,817
+10,903
+16% +$1.43M 1.28% 37
2021
Q3
$9.79M Buy
68,914
+2,095
+3% +$308K 1.38% 34
2021
Q2
$10.4M Sell
66,819
-288
-0.4% -$46.7K 1.5% 32
2021
Q1
$10.4M Sell
67,107
-4,249
-6% -$658K 1.56% 29
2020
Q4
$10.7M Sell
71,356
-4,449
-6% -$628K 1.8% 22
2020
Q3
$10M Sell
75,805
-1,494
-2% -$195K 1.95% 22
2020
Q2
$8.96M Buy
77,299
+919
+1% +$106K 1.72% 25
2020
Q1
$7.5M Buy
76,380
+1,068
+1% +$140K 1.71% 27
2019
Q4
$10.9M Sell
75,312
-1,585
-2% -$219K 1.79% 24
2019
Q3
$10.2M Sell
76,897
-12,305
-14% -$1.59M 1.81% 24
2019
Q2
$10.2M Sell
89,202
-10,092
-10% -$1.18M 1.81% 23
2019
Q1
$12.3M Sell
99,294
-3,021
-3% -$343K 2.1% 18
2018
Q4
$10.3M Sell
102,315
-1,160
-1% -$130K 1.91% 20
2018
Q3
$13.2M Sell
103,475
-9,913
-9% -$1.18M 2.11% 18
2018
Q2
$12.3M Sell
113,388
-2,544
-2% -$277K 2.02% 20
2018
Q1
$12.3M Sell
115,932
-3,058
-3% -$355K 2.02% 19
2017
Q4
$13.9M Buy
118,990
+3,264
+3% +$369K 2.21% 18
2017
Q3
$13.2M Sell
115,726
-463
-0.4% -$53.4K 2.17% 19
2017
Q2
$14.5M Sell
116,189
-3,862
-3% -$458K 2.48% 16
2017
Q1
$14.2M Sell
120,051
-15,783
-12% -$1.79M 2.5% 15
2016
Q4
$13.6M Buy
135,834
+26,778
+25% +$2.87M 2.31% 18
2016
Q3
$13.8M Sell
109,056
-10,221
-9% -$1.26M 2.43% 13
2016
Q2
$13.9M Sell
119,277
-7,247
-6% -$820K 2.71% 11
2016
Q1
$13.1M Sell
126,524
-2,258
-2% -$218K 2.58% 12
2015
Q4
$12.8M Sell
128,782
-72,305
-36% -$7.07M 2.47% 14
2015
Q3
$18.3M Buy
201,087
+622
+0.3% +$62.4K 2.62% 16
2015
Q2
$21.3M Sell
200,465
-4,967
-2% -$550K 2.67% 18
2015
Q1
$23.4M Sell
205,432
-33,220
-14% -$3.79M 2.71% 16
2014
Q4
$26.3M Sell
238,652
-11,660
-5% -$1.23M 2.97% 10
2014
Q3
$24.4M Sell
250,312
-4,627
-2% -$455K 2.84% 14
2014
Q2
$25.7M Sell
254,939
-12,031
-5% -$1.17M 2.92% 13
2014
Q1
$24.5M Sell
266,970
-5,372
-2% -$495K 2.93% 12
2013
Q4
$24.6M Sell
272,342
-8,485
-3% -$734K 2.99% 10
2013
Q3
$22.4M Sell
280,827
-15,733
-5% -$1.24M 3.02% 13
2013
Q2
$21.6M Buy
+296,560
New +$22.2M 3.01% 14

Other funds holding ZBH

Matrix Asset Advisors's ZBH Position: Q1 2026 in Review

Matrix Asset Advisors sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 30,032 shares — an estimated $2.7M sold.

Matrix Asset Advisors first reported a position in ZBH in Q2 2013 and held it in 51 quarters. The position peaked at $26.3M in Q4 2014. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Matrix Asset Advisors reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Matrix Asset Advisors sold 30,032 Zimmer Biomet shares in Q1 2026, an estimated $2.7M.
  • Matrix Asset Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 51 quarters.
  • Matrix Asset Advisors's Zimmer Biomet position peaked at $26.3M in Q4 2014.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Matrix Asset Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.